• NEWS
  • NEWS
  • NEWS
  • NEWS
  • NEWS
  • NEWS

The latest news on XGEN and its companies.

Follow us on LinkedIn

Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the...
Focalis Bio, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the...
Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA)...
Focalis Bio, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced...
PAGE Therapeutics is a Swiss preclinical-stage biotechnology company spun out of ETH Zurich, based on the groundbreaking science of Prof....
PAGE Therapeutics is a Swiss preclinical-stage biotechnology company spun out of ETH Zurich, based on the groundbreaking science of Prof....